XPR – Lifestyle Demo
Author:
Mezzion Pharmaceuticals, Inc
Mezzion Secures Strategic Financing to Support Advancement of Global Phase 3 FUEL-2 Trial in Fontan Patients
May 14, 2026
Mezzion Reports Pre-IND FDA Feedback on the Development of Udenafil in ADPKD
May 7, 2026